RU2002107139A - Swine culture inactivated chlamydia vaccine - Google Patents

Swine culture inactivated chlamydia vaccine

Info

Publication number
RU2002107139A
RU2002107139A RU2002107139/13A RU2002107139A RU2002107139A RU 2002107139 A RU2002107139 A RU 2002107139A RU 2002107139/13 A RU2002107139/13 A RU 2002107139/13A RU 2002107139 A RU2002107139 A RU 2002107139A RU 2002107139 A RU2002107139 A RU 2002107139A
Authority
RU
Russia
Prior art keywords
chlamydia
swine
vaccine
vgnki
suis
Prior art date
Application number
RU2002107139/13A
Other languages
Russian (ru)
Other versions
RU2233670C2 (en
Inventor
Галина Петровна Щербань
Галина Николаевна Данченко
Татьяна Федоровна Кравченко
Original Assignee
Галина Петровна Щербань
Галина Николаевна Данченко
Татьяна Федоровна Кравченко
Filing date
Publication date
Application filed by Галина Петровна Щербань, Галина Николаевна Данченко, Татьяна Федоровна Кравченко filed Critical Галина Петровна Щербань
Priority to RU2002107139/13A priority Critical patent/RU2233670C2/en
Priority claimed from RU2002107139/13A external-priority patent/RU2233670C2/en
Publication of RU2002107139A publication Critical patent/RU2002107139A/en
Application granted granted Critical
Publication of RU2233670C2 publication Critical patent/RU2233670C2/en

Links

Claims (1)

Вакцина против хламидиоза свиней культуральная инактивированная, содержащая антиген хламидий, адъювант и инактиватор, отличающаяся тем, что в качестве антигена она содержит штамм Chlamydia psittaci (var. suis) ВГНКИ "SR" №14, в качестве антигена штамм Chlamydia psittaci (var. suis) ВГНКИ "SR" №14, выращенный на монослое первичной культуры клеток фибробластов эмбрионов кур (ФЭК) с титром не ниже 10-7 ТЦД50/мл, причем вакцина также содержит инактиватор - фенол и адъювант - поливинилпирролидон при следующем соотношении их, мас.%:Pig chlamydia vaccine is a culture inactivated vaccine containing chlamydia antigen, adjuvant and inactivator, characterized in that it contains the Chlamydia psittaci strain (var. Suis) VGNKI SR No. 14 as the antigen, the Chlamydia psittaci strain (var. Suis) as the antigen VGNKI "SR" No. 14, grown on a monolayer of the primary culture of chicken embryo fibroblast cells (FEC) with a titer of at least 10 -7 TCD 50 / ml , and the vaccine also contains an inactivator - phenol and adjuvant - polyvinylpyrrolidone in the following ratio, wt.% : Суспензия клеток ФЭК, инфицированных хламидиями штамма Chlamydia psittaci (var. suis) ВГНКИ "SR" №14, с титром не ниже 10-7 ТЦД50/мл 99,0-99,5Suspension of FEC cells infected with chlamydia strain Chlamydia psittaci (var. Suis) VGNKI "SR" No. 14, with a titer of at least 10 -7 TCD 50 / ml 99.0-99.5 Фенол 0,3-0,5Phenol 0.3-0.5 Поливинилпирролидон 0,4-0,6Polyvinylpyrrolidone 0.4-0.6
RU2002107139/13A 2002-03-21 2002-03-21 Cultural inactivated vaccine against chlamydiosis in pigs RU2233670C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002107139/13A RU2233670C2 (en) 2002-03-21 2002-03-21 Cultural inactivated vaccine against chlamydiosis in pigs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002107139/13A RU2233670C2 (en) 2002-03-21 2002-03-21 Cultural inactivated vaccine against chlamydiosis in pigs

Publications (2)

Publication Number Publication Date
RU2002107139A true RU2002107139A (en) 2003-09-27
RU2233670C2 RU2233670C2 (en) 2004-08-10

Family

ID=33412347

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002107139/13A RU2233670C2 (en) 2002-03-21 2002-03-21 Cultural inactivated vaccine against chlamydiosis in pigs

Country Status (1)

Country Link
RU (1) RU2233670C2 (en)

Similar Documents

Publication Publication Date Title
CY1106848T1 (en) MODIFIED VACCINIA ANKARA VIRUS FOR NEWBORN VACCINATION
GB9818627D0 (en) Improvements in dva vaccination
DE69734882D1 (en) DNA IMMUNIZATION AGAINST CHLAMYDIA INFECTION
AU4055989A (en) Novel infectious bursal disease virus
BR0012433A (en) Recombinant virus, infectious from infectious bursal disease, method to obtain the same, ibdv infectious mosaic (mibdv), and vaccine
RU2002107139A (en) Swine culture inactivated chlamydia vaccine
RU2002107140A (en) VACCINE CULTURAL INACTIVATED AGAINST CHLAMIDIOSIS OF CATTLE AND SMALL CATTLE
CA2327434A1 (en) Dna immunization against chlamydia infection
RU2003129571A (en) VACCINE CULTURAL INACTIVATED AGAINST CHLAMIDIOSIS (ORNITOSIS) OF BIRDS
MXPA01005808A (en) Ibdv strain for in ovo administration.
RU95103695A (en) VACCINE CULTURAL INACTIVATED AGAINST CHLAMIDIOSIS (ORNITOSIS) OF BIRDS
EP0704529A3 (en) Vaccine against rabbit hemorrhagic disease virus
EP1650225A4 (en) Hetero type pentamer recombinant vaccine
AU6605190A (en) Novel infectious bursal disease virus
Esterhuysen The antigenic variation of foot-and-mouth disease viruses and its significance in the epidemiology of the disease in southern Africa.
WO2003031470A3 (en) Dna-expression construct for treatment of infections with leishmaniasis
RU2001134539A (en) Dog Coronavirus Enteritis Vaccine
BR9911388A (en) Synthetic somatostatin immunogen for growth promotion in farm animals
RU2002130881A (en) VACCINE AGAINST VIRUS HEMORRHAGIC RABBIT DISEASE
MXPA01006919A (en) A broad spectrum infectious bursal disease virus vaccine.
EP1161953A3 (en) IBDV strain for in OVO administration
AJDINSKI THE DECISION FOR ORGANIZING THE POSTGRADUATE STUDIES AT THE INSTITUTE OF DEFECTOLOGY-FACULTY OF PHILOSOPHY IS MADE
Archakov Bioinformatics, genomics and proteonics-life sciences of the XXI century
RU96114608A (en) VACCINE AGAINST HELMINTHES
RU2002135777A (en) VACCINE FOR SPECIFIC PREVENTION OF PIG CHLAMIDIOSIS